Search Results for: chronic plaque psoriasis

January 26, 2017

FDA Approves Generic Version of Topicort Spray for Plaque Psoriasis

News

The U.S. Food and Drug Administration (FDA) has approved Perrigo’s generic version of Topicort (desoximetasone topical spray, 0.25%) to treat plaque psoriasis, the company announced. Topicort, owned by Taro Pharmaceuticals US, is a ... Read more

January 19, 2017January 19, 2017

Coherus Reports Positive 24-Week Trial Results for Humira Biosimilar in Psoriasis Patients

News

Coherus BioSciences recently reported positive 24-week results from the second part of a three-part Phase 3 clinical trial comparing biosimilar CHS-1420, a therapy candidate for plaque psoriasis, to Humira (adalimumab). The results from ... Read more

January 5, 2017

Licensing Deal Worth $790M Reached For Potential Psoriasis Treatment, AST-005

News

Purdue Pharma and Exicure have announced a strategic research alliance and licensing agreement for AST-005, a potential treatment for psoriasis and other diseases amenable to a gene regulation approach by Exicure ... Read more

December 15, 2016

Phase 2 Study of Oral Treatment for Plaque Psoriasis, LYC-30937-EC, Starts in US

News

Lycera announced the start of a Phase 2 clinical trial testing its lead candidate, LYC-30937-Enteric Coated, as an oral treatment for moderate chronic plaque psoriasis. The randomized, placebo-controlled and double-blind study, called UPRISE (NCT02872285), will ... Read more

November 8, 2016November 8, 2016

FDA Approves Enbrel as First Biologic Treatment for Children with Plaque Psoriasis

News

The U.S. Food and Drug Administration (FDA) has agreed to the expanded use of Enbrel (etanercept) to treat children with chronic moderate-to-severe plaque psoriasis, making Amgen’s biologic the first systematic therapy approved for pediatric patients ... Read more

September 29, 2016

FDA Approves Amjevita as Humira Biosimilar to Treat Psoriasis and Other Inflammatory Diseases

News

The U.S. Food and Drug Administration (FDA) has approved Amgen’s Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab, AbbVie) for use in multiple inflammatory diseases, including psoriasis. Amjevita is now approved ... Read more

September 7, 2016September 7, 2016

Erelzi, Biosimilar to Enbrel, Approve to Treat Certain Psoriasis Patients

News

The U.S. Food and Drug Administration has approved Erelzi (etanercept-szzs), a biosimilar to the already licensed drug Enbrel (etanercept), for the treatment of multiple inflammatory diseases, including psoriasis. Erelzi may be used as ... Read more

August 30, 2016

Spherical RNA Has Potential to Be Promising Psoriasis Therapy, According to First Human Trial

News

A new type of RNA therapy, spherical nucleic acid (SNA), looks promising in the first human trial in patients with psoriasis. The results were recently presented at the American Chemical Society (ACS) meeting ... Read more

August 17, 2016August 17, 2016

Survey of Psoriasis Patients Highlights Disease’s Emotional Toll, Treatment Challenges

News

A new survey by Health Union, titled “Psoriasis in America 2016,” has revealed that although psoriasis patients agree that a variety of treatment plans are available, they find it difficult to find one that ... Read more

August 15, 2016August 15, 2016

Biologics May Be Effective Option for Children with Generalized Pustular Psoriasis

News

Biologics may be a promising treatment for pediatric patients with generalized pustular psoriasis (GPP) who are not responding to traditional therapies, but clinical trials better establishing their safety and efficacy ... Read more